Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry

被引:36
作者
Willis, C
Taylor, PJ
Salm, P
Tett, SE
Pillans, PI
机构
[1] Univ Queensland, Princess Alexandra Hosp, Dept Med, Brisbane, Qld 4102, Australia
[2] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia
[3] Princess Alexandra Hosp, Dept Clin Pharmacol, Brisbane, Qld 4102, Australia
来源
JOURNAL OF CHROMATOGRAPHY B | 2000年 / 748卷 / 01期
基金
英国医学研究理事会;
关键词
mycophenolic acid;
D O I
10.1016/S0378-4347(00)00273-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To facilitate the investigation of free mycophenolic acid concentrations we developed a high-performance liquid chromatography tandem mass spectrometry method using indomethacin as an internal standard. Free drug was isolated from plasma samples (500 mul) using ultrafiltration, The analytes were extracted from the ultrafiltrate (200 mul) using C-18 solid-phase extraction. Detection was by selected reactant monitoring of mycophenolic acid (m/z 318.9-->190.9) and the internal standard (m/z 356.0-->297.1) with an atmospheric pressure chemical ionisation interface. The total chromatographic analysis time was 12 min. The method was found to be linear over the range investigated, 2.5-200 mug/l (r>0.990, n=6). The relative recovery of the method for the control samples studied (7.5, 40.0 and 150 mug/l) ranged from 95 to 104%. The imprecision of the method, expressed in terms of intra- and inter-day coefficients of variation, was <8 and <9%, respectively. Further, analysis of pooled patient plasma produced an intra-day imprecision of 6.6%. The signal-to-noise ratio at the limit of quantification (2.5 mug/l) was approximately 5:1. The mean absolute recovery (n=6) of mycophenolic acid and the internal standard were 76.0+/-13.5% and 86.0+/-9.1%, respectively. The method reported provides an accurate and precise quantification of free mycophenolic acid over a wide analytical range and thus can be used for routine monitoring and pharmacokinetic studies. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 18 条
[1]   Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration [J].
Bullingham, R ;
Monroe, S ;
Nicholls, A ;
Hale, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04) :315-324
[2]   Clinical pharmacokinetics of mycophenolate mofetil [J].
Bullingham, RES ;
Nicholls, AJ ;
Kanmm, BR .
CLINICAL PHARMACOKINETICS, 1998, 34 (06) :429-455
[3]   IMMUNOSUPPRESSIVE ACTIVITY OF MYCOPHENOLATE MOFETIL [J].
EUGUI, EM ;
ALLISON, AC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 685 :309-329
[4]   A reference method for the analysis of aldosterone in blood by high-performance liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry [J].
Fredline, VF ;
Taylor, PJ ;
Dodds, HM ;
Johnson, AG .
ANALYTICAL BIOCHEMISTRY, 1997, 252 (02) :308-313
[5]   Mycophenolate mofetil - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation [J].
Fulton, B ;
Markham, A .
DRUGS, 1996, 51 (02) :278-298
[6]   The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients [J].
Johnson, AG ;
Rigby, RJ ;
Taylor, PJ ;
Jones, CE ;
Allen, J ;
Franzen, K ;
Falk, MC ;
Nicol, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (05) :492-500
[7]   High-performance liquid chromatography determination of mycophenolic acid and its glucuronide metabolite in human plasma [J].
Jones, CE ;
Taylor, PJ ;
Johnson, AG .
JOURNAL OF CHROMATOGRAPHY B, 1998, 708 (1-2) :229-234
[8]  
NOWAK I, 1995, CLIN CHEM, V41, P1011
[9]   MECHANISM OF ACTION OF MYCOPHENOLATE MOFETIL [J].
RANSOM, JT .
THERAPEUTIC DRUG MONITORING, 1995, 17 (06) :681-684
[10]   ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE, AND PHARMACOKINETIC STUDIES [J].
SHAH, VP ;
MIDHA, KK ;
DIGHE, S ;
MCGILVERAY, IJ ;
SKELLY, JP ;
YACOBI, A ;
LAYLOFF, T ;
VISWANATHAN, CT ;
COOK, CE ;
MCDOWALL, RD ;
PITTMAN, KA ;
SPECTOR, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (03) :309-312